SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : GSII - GENERAL SURGICAL INNOVATIONS, INC.

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Lighthouse who wrote (162)2/2/1999 5:07:00 PM
From: Epics  Read Replies (1) of 211
 
GDT having ligigation with another firm, they took them over and took
a charge.. GSII up 1/2 in late trading.. hmm.. maybe?

02/02 3:28P (DJ) =Media Barred From Guidant Presentation At N.Y. Conference
After completing the acquisition of Sulzer Medica's electrophysiology
business Monday, Guidant announced earlier Tuesday that it will post a first
quarter pretax charge of $49 million related to the deal. The charge
represents the value ascribed to in-process technology, the company said in a
press release.
Guidant had previously charged its third quarter in 1998 with $200 million
of the purchase price ascribed to settlement of intellectual property
litigation.
Also Tuesday, Guidant said discussions are underway with parties interested
in the purchase of Osypka and Oscor, both parts of Sulzer's electrophysiology
business. The products made by Osypka and Oscor are not part of Guidant's
long-term CRM strategy, the company said.
Shares of Guidant were recently trading at 53 15/16, down 4 7/16, or 7.6%.
Guidant last week reported 1998 earnings of $43.8 million, or 14 cents a
diluted share including charges. Excluding charges, net income was $359.4
million, or $1.19 a diluted share. Sales in 1998 totaled $1.9 billion.

Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext